Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,423 | 188,893 | 34,863 | 15,142 | 90,095 |
| Marketable Securities | 513,665 | 150,384 | 20,848 | 77,986 | 56,178 |
| Receivables | N/A | N/A | 375 | 815 | N/A |
| TOTAL | $608,474 | $341,528 | $62,258 | $98,891 | $149,789 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 3,220 | 4,549 | 5,642 |
| Other Non-Current Assets | 10 | 331 | 5,666 | 6,486 | 6,187 |
| TOTAL | $10 | $331 | $8,886 | $11,035 | $11,829 |
| Total Assets | $608,484 | $341,859 | $71,144 | $109,926 | $161,618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,269 | 17,480 | 677 | 3,319 | 2,254 |
| Accrued Expenses | 27,711 | 13,108 | 12,837 | 14,030 | 13,870 |
| Other current liabilities | 25,080 | 1,390 | 0 | N/A | N/A |
| TOTAL | $54,060 | $31,978 | $14,656 | $20,144 | $16,443 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 517 | 2,359 | 0 |
| Other Non-Current Liabilities | 36,620 | 125,865 | 4,004 | 4,624 | 5,343 |
| TOTAL | $36,620 | $125,865 | $6,183 | $5,841 | $5,343 |
| Total Liabilities | $90,680 | $157,843 | $20,839 | $25,985 | $21,786 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,276 | 36,151 | 2,616 | 1,974 | 1,921 |
| Common Shares | 13 | 10 | 6 | 5 | 5 |
| Retained earnings | -972,432 | -764,414 | -425,624 | -341,809 | -276,008 |
| Other shareholders' equity | 156,000 | 185,229 | -48 | -20 | 11 |
| TOTAL | $517,804 | $184,016 | $50,305 | $83,941 | $139,832 |
| Total Liabilities And Equity | $608,484 | $341,859 | $71,144 | $109,926 | $161,618 |